Phoenicibacter congonensis

(aka Phoenicibacter massiliensis)

Bacteria


General | Carbohydrate O/F | Substrate utilisation | Enzymes | Metabolites | Antibiotics

Overview


  • Phoenicibacter congonensis, (aka Phoenicibacter massiliensis), is a Gram-positive, non-spore-forming, strictly anaerobic, non-motile, coccobacillus bacterium. It has been detected in at least 1 gut microbiome compilation study or metastudy. The DNA G+C content is 43.4%. Phoenicibacter congonensis is probably a rare gut coloniser. (Bilen2017f; Bilen2018d)



  • This organism has been recovered from human faeces (Bilen2018d). Pathogenicity status unknown, or very unlikely to be pathogenic. A possible gut commensal.

  • GENERAL CHARACTERISTICS (Bilen2017f); (Bilen2018d);
    Character Response
  • 🧂
  • Salt tolerance:
  • tolerates 0.5% salt;
  • pH
  • Acidity tolerance:
  • tolerates pH 6.0-8.0; tolerates pH 8.5;
  • 🌡
  • Temperature tolerance:
  • grows at 37℃; grows at 42℃; Grows optimally at 37℃.
  • H+
  • Acid from carbohydrates usually produced:
  • L-arabinose; fructose; D-fucose; galactose; glucose; mannose; rhamnose; ribose; sorbose; xylose; aesculin; starch; cellubiose; gentiobiose; lactose; maltose; melibiose; raffinose; sucrose; trehalose; D-turanose; adonitol; D-arabitol; L-arabitol; dulcitol; glycerol; inositol; mannitol; sorbitol; arbutin; gluconate; 2-ketogluconate; 5-ketogluconate; α-methyl glucoside; methyl mannoside; N-Ac glucosamine; salicin;
  • Substrates assimilated or utilised:
  • arabinose; cellubiose; glucose; glycerol; maltose; mannitol; mannose; melezitose; rhamnose; raffinose; salicin; sorbitol; sucrose; trehalose; xylose;
  • Active enzymes:
  • N-Ac β-glucosaminidase; urease;

  • SPECIAL FEATURES (Bilen2017f); (Bilen2018d);
    Character Response
  • Metabolites produced:
  • propionate; butyrate; indole;

  • RESPONSE TO ANTIBIOTICS (Bilen2017f); (Bilen2018d);
    Class Active Resistant
  • Penicillins:
  • amoxicillin; benzylpenicillin; imipenem;
  • Cephalosporins:
  • cefotaxime;
  • Macrolides:
  • erythromycin;
  • Tetracyclines:
  • tigecycline;
  • Aminoglycosides:
  • amikacin;
  • Polypep/ketides:
  • rifampicin;
  • Heterocycles:
  • metronidazole;
  • Vancomycins:
  • vancomycin; teicoplanin;
  • Miscellaneous antibiotics:
  • colistin;

  • Details


    GENERAL
    Lineage Physiology General Growth Tolerances Hydrol./digest./degr.
    Phylum:  Actinobacteria Class:  Coriobacteriia Order:  Eggerthellales Family:  Eggerthellaceae Genus:  Phoenicibacter Alt. name:  Phoenicibacter massiliensis Gram stain:  + O2 Relation.:  strictly anaerobic Spore:  No spore Motility:  Sessile Morphology:  Coccobacillus
    Health:  Unknown
    Source:  human faeces (Bilen2018d)
    DNA G+C(%):  43.4
    Opt. T:  37℃
    Mid T(℃):  37(+)
    High T(℃):  42(+)
    NaCl 0.5-2%:  0.5(+)
    pH 6.0-8.0:  6.0-8.0(+)
    pH >8:  8.5(+)

    CARBOHYDRATE ACID FORMATION
    Monosaccharide O/F Oligosaccharide O/F Polysaccharide O/F Polyol O/F Other O/F
    L-Arabinose:  + Fructose:  + D-Fucose:  + Galactose:  + Glucose:  + Mannose:  + Rhamnose:  + Ribose:  + Sorbose:  + Xylose:  + Cellubiose:  + Gentiobiose:  + Lactose:  + Maltose:  + Melibiose:  + Sucrose:  + Trehalose:  + Turanose:  + Aesculin:  + Starch:  + Adonitol:  + D-Arabitol:  + L-Arabitol:  + Dulcitol:  + Glycerol:  + Inositol:  + Mannitol:  + Sorbitol:  + Arbutin:  + Gluconate:  + 2-Ketogluconate:  + 5-Ketogluconate:  + Me-α-D-Glc:  + Me-α-D-Mann:  + NAc-α-GA:  + Salicin:  +

    SUBSTRATE ASSIMILATION & UTILISATION
    Monosaccharide util/assim Oligosaccharide util/assim Other carboh. util/assim Amino acid util/assim Organic acid util/assim
    Arabinose:  + Glucose:  + Mannose:  + Rhamnose:  + Xylose:  + Cellubiose:  + Maltose:  + Melezitose:  + Raffinose:  + Sucrose:  + Trehalose:  + Glycerol:  + Mannitol:  + Salicin:  + Sorbitol:  +

    ENZYME ACTIVITY
    Enzymes: General Enzymes: Carbohydrate Enzymes: Protein Enzymes: Arylamidases Enzymes: Esters/fats
    Oxidase:  neg Catalase:  neg Urease:  + Ac-β-glcamnd:  + β-Galactosidase:  neg

    METABOLITES - PRODUCTION & USE
    Fuel Usable Metabolites Metabolites Released Special Products Compounds Produced

    Propionate:  + Butyrate:  + Indole:  +

    ANTIBIOTICS ℞
    Penicillins & Penems (μg/mL) Cephalosporins (μg/mL) Aminoglycosides (μg/mL) Macrolides (μg/mL) Quinolones (μg/mL)
    amoxicillin:  S(0.032)
    benzyl-pen:  S(0.006)
    imipenem:  S(0.012)
    cefotaxime:  S(0.064)
    amikacin:  R(32)
    erythromycin:  S(0.016)
    Tetracyclines (μg/mL) Vancomycin Class (μg/mL) Polypep/ketides (μg/mL) Heterocycles (μg/mL) Other (μg/mL)
    tigecycline:  S(0.032)
    teicoplanin:  S(0.032)
    vancomycin:  S(0.25)
    rifampicin:  S(0.047)
    metronidazole:  S(0.023)
    daptomycin:  Var(MIC50): 6), MIC90: Var(6
    colistin:  R(>256)

    References


    SPECIFIC REFERENCES FOR PHOENICIBACTER CONGONENSIS
  • Bilen2017f - 'Phoenicibacter massiliensis' gen. nov., sp. nov., a new bacterium isolated from the human gut of a pygmy woman.
  • Bilen2018d - Phoenicibacter congonensis gen. nov., sp. nov., a new genus isolated from the human gut and its description using a taxonogenomic approach.
  • ...............................
  • GUT MICROBIOME COMPILATIONS AND METASTUDIES FOR PHOENICIBACTER CONGONENSIS
  • New2022 - Collective effects of human genomic variation on microbiome function.
  • ...............................
  • GENERAL REFERENCES FOR PHOENICIBACTER CONGONENSIS
  • CCUG - Culture Collection University of Gothenburg - Entire Collection